Background and Need for Legislation
Autism affects an estimated 1 in 36 children in the United
States.\1\ Behavioral signs of autism usually appear early in
development, often as early as 12 to 18 months of age or
earlier.\2\ Research shows that early intervention and
therapies lead to positive outcomes later in life for
individuals with autism.\3\
---------------------------------------------------------------------------
\1\Maenner MJ, Warren Z, Williams AR, et al. Prevalence and
Characteristics of Autism Spectrum Disorder Among Children Aged 8
Years--Autism and Developmental Disabilities Monitoring Network, 11
Sites, United States, 2020. MMWR Surveill Summ 2023;72 (No. SS-2):1-14.
DOI:http://dx.doi.org/10.15585/mmwr.ss7202a1.
\2\``When do children usually show symptoms of autism?,'' National
Institutes of Health, Eunice Kennedy Shriver National Institute of
Child Health and Human Development, January 31, 2017, https://
www.nichd.nih.gov/health/topics/autism/conditioninfo/symptoms-appear.
\3\``Autism spectrum disorder (ASD), What is autism?,'' Autism
Speaks, https://www.autismspeaks.org/what-is-autism.
---------------------------------------------------------------------------
First signed into law in 2006, the CARES Act funds programs
to directly improve the quality of lives of individuals with
Autism, their families, and their caregivers. The current
authorization for these programs expires September 30, 2024.
H.R. 7213 would support and enhance existing programs
related to autism spectrum disorder, including improving
research coordination and research into evidence-based
interventions, ensuring research is reflective of the entire
population of individuals with autism spectrum disorder,
continuing surveillance and early identification programs, and
facilitating increased and robust opportunities for public
input. The legislation also strengthens existing education and
training programs for providers, and requires updated strategic
plans and progress reports, as well as an annual budget plan to
carry out such strategic planning.
Committee Action
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7213. The title of the hearing was
``Legislative Proposals to Support Patients and Caregivers.''
The Subcommittee received testimony from:
Andy Shih, PhD, Chief Science Officer,
Autism Speaks;
Corey Feist, JD, MBA, Co-Founder and CEO,
Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and CEO,
Alzheimer's Association;
Gordon Tomaselli, MD, Former President,
American Heart Association; Marilyn and Stanley M. Katz
Dean, Emeritus and Professor of Medicine, Albert
Einstein College of Medicine; Adjunct Professor of
Medicine, Johns Hopkins University School of Medicine;
Michelle Whitten, President, CEO, and Co-
Founder, Global Down Syndrome Foundation;
Randy Strozyk, President, American Ambulance
Association; and
Christina Annunziata, MD, PhD, Senior Vice
President of Extramural Discovery Science, American
Cancer Society.
On May 16, 2024, the Subcommittee on Health met in open
markup session and forwarded H.R. 7213, as amended, to the full
Committee by a record vote of 22 yeas to 0 nays.
On June 12, 2024, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 7213, as amended,
favorably reported to the House by a record vote of 42 yeas and
0 nays.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to
reauthorize and make improvements to activities and programs
relating to autism spectrum disorder.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 7213 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
related hearing was used to develop or consider H.R. 7213:
On February 14, 2024, the Subcommittee on
Health held a hearing on H.R. 7213. The title of the
hearing was ``Legislative Proposals to Support Patients
and Caregivers.'' The Subcommittee received testimony
from:
Andy Shih, PhD, Chief Science
Officer, Autism Speaks;
Corey Feist, JD, MBA, Co-Founder
and CEO, Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and
CEO, Alzheimer's Association;
Gordon Tomaselli, MD, Former
President, American Heart Association; Marilyn
and Stanley M. Katz Dean, Emeritus and
Professor of Medicine, Albert Einstein College
of Medicine; Adjunct Professor of Medicine,
Johns Hopkins University School of Medicine;
Michelle Whitten, President,
CEO, and Co-Founder, Global Down Syndrome
Foundation;
Randy Strozyk, President,
American Ambulance Association; and
Christina Annunziata, MD, PhD,
Senior Vice President of Extramural Discovery
Science, American Cancer Society.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 7213 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides that the Act may be cited as the
``Autism Collaboration, Accountability, Research, Education,
and Support Act of 2024,'' or the ``Autism CARES Act of 2024''.
Section 2. National Institutes of Health activities
Section 2 expands and improves coordination of research
related to autism spectrum disorder within the National
Institutes of Health (NIH), including by ensuring such research
reflects the entire population of individuals with autism
spectrum disorder, and is informed by opportunities for public
input. This section also increases the minimum number of
currently existing centers of excellence from five to six.
Section 3. Programs relating to autism
Section 3 enhances existing education, early detection, and
intervention training efforts by including parents and
guardians as eligible participants and ensuring such efforts
will appropriately serve patients with autism spectrum
disorder. This section also requires the Interagency Autism
Coordinating Committee (IACC) to develop updated strategic
plans and reports, including progress made to implement the
recommendations and strategies. In addition, this section
requires a professional judgment budget for carrying out the
strategic plan.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
PART R--PROGRAMS RELATING TO AUTISM
SEC. 399AA. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND RESEARCH
PROGRAM.
(a) Autism Spectrum Disorder and Other Developmental
Disabilities.--
(1) In general.--The Secretary, acting through the
Director of the Centers for Disease Control and
Prevention, may award grants or cooperative agreements
to eligible entities for the collection, analysis, and
reporting of State epidemiological data for children
and adults with autism spectrum disorder and other
developmental disabilities. An eligible entity shall
assist with the development and coordination of State
autism spectrum disorder and other developmental
disability surveillance efforts within a region. In
making such awards, the Secretary may provide direct
technical assistance in lieu of cash.
(2) Data standards.--In submitting epidemiological
data to the Secretary pursuant to paragraph (1), an
eligible entity shall report data according to
guidelines prescribed by the Director of the Centers
for Disease Control and Prevention, after consultation
with relevant State, local, and Tribal public health
officials, private sector developmental disability
researchers, and advocates for individuals with autism
spectrum disorder and other developmental disabilities.
(3) Eligibility.--To be eligible to receive an award
under paragraph (1), an entity shall be a public or
nonprofit private entity (including a health department
of a State or a political subdivision of a State, a
university, any other educational institution, an
Indian tribe, or a tribal organization), and submit to
the Secretary an application at such time, in such
manner, and containing such information as the
Secretary may require.
(b) Centers of Excellence in Autism Spectrum Disorder
Epidemiology.--
(1) In general.--The Secretary, acting through the
Director of the Centers for Disease Control and
Prevention, shall, subject to the availability of
appropriations, award grants or cooperative agreements
for the establishment or support of regional centers of
excellence in autism spectrum disorder and other
developmental disabilities epidemiology for the purpose
of collecting and analyzing information on the number,
incidence, correlates, [and causes] causes, and life
course of autism spectrum disorder and other
developmental disabilities for children and adults.
(2) Requirements.--To be eligible to receive a grant
or cooperative agreement under paragraph (1), an entity
shall submit to the Secretary an application containing
such agreements and information as the Secretary may
require, including an agreement that the center to be
established or supported under the grant or cooperative
agreement shall operate in accordance with the
following:
(A) The center will collect, analyze, and
report autism spectrum disorder and other
developmental disability data according to
guidelines prescribed by the Director of the
Centers for Disease Control and Prevention,
after consultation with State, local, and
Tribal public health officials, private sector
developmental disability researchers, advocates
for individuals with autism spectrum disorder,
and advocates for individuals with other
developmental disabilities.
(B) The center will develop or extend an area
of special research expertise (including
genetics, epigenetics, and epidemiological
research related to environmental exposures),
immunology, and other relevant research
specialty areas.
(C) The center will identify eligible cases
and controls through its surveillance system
and conduct research into factors which may
cause or increase the risk of autism spectrum
disorder and other developmental disabilities.
(c) Federal Response.--The Secretary shall coordinate the
Federal response to requests for assistance from State health,
mental health, and education department officials regarding
potential or alleged autism spectrum disorder or developmental
disability clusters.
(d) Definitions.--In this part:
(1) Indian tribe; tribal organization.--The terms
``Indian tribe'' and ``tribal organization'' have the
meanings given such terms in section 4 of the Indian
Health Care Improvement Act.
(2) Other developmental disabilities.--The term
``other developmental disabilities'' has the meaning
given the term ``developmental disability'' in section
102(8) of the Developmental Disabilities Assistance and
Bill of Rights Act of 2000 (42 U.S.C. 15002(8)).
(3) State.--The term ``State'' means each of the
several States, the District of Columbia, the
Commonwealth of Puerto Rico, American Samoa, Guam, the
Commonwealth of the Northern Mariana Islands, the
Virgin Islands, and the Trust Territory of the Pacific
Islands.
(e) Sunset.--This section shall not apply after September 30,
[2024] 2029.
SEC. 399BB. AUTISM EDUCATION, EARLY DETECTION, AND INTERVENTION.
(a) Purpose.--It is the purpose of this section--
(1) to increase awareness, reduce barriers to
screening and diagnosis, promote evidence-based
interventions for individuals with autism spectrum
disorder and other developmental disabilities, and
train professionals to utilize valid and reliable
screening tools to diagnose or rule out and provide
evidence-based interventions for individuals with
autism spectrum disorder and other developmental
disabilities across their lifespan; and
(2) to conduct activities under this section with a
focus on an interdisciplinary approach (as defined in
programs developed under section 501(a)(2) of the
Social Security Act) that will also focus on specific
issues for children who are not receiving an early
diagnosis and [subsequent interventions] subsequent
interventions and services.
(b) In General.--The Secretary shall, subject to the
availability of appropriations, establish and evaluate
activities to--
(1) provide [culturally competent information]
culturally and linguistically responsive information
and education on autism spectrum disorder and other
developmental disabilities to increase public awareness
of developmental milestones;
(2) [promote research] promote research, which may
include community-based participatory research, into
the development and validation of reliable [screening
tools] screening and diagnostic tools for individuals
with autism spectrum disorder and other developmental
disabilities and disseminate information regarding
those [screening tools] screening and diagnostic tools;
(3) promote early screening of individuals [at higher
risk] at increased likelihood for autism spectrum
disorder and other developmental disabilities as early
as practicable, given evidence-based screening
techniques and interventions;
(4) promote evidence-based screening techniques and
interventions for individuals with autism spectrum
disorder and other developmental disabilities across
their lifespan, which may include such individuals
utilizing parents and guardians trained to provide
interventions, services, and supports;
(5) increase the number of individuals who are able
to confirm or rule out a diagnosis of autism spectrum
disorder and other developmental disabilities;
(6) increase the number of individuals able to
provide evidence-based interventions for individuals
diagnosed with autism spectrum disorder or other
developmental disabilities; and
(7) promote the use of evidence-based interventions
for individuals at higher risk for autism spectrum
disorder and other developmental disabilities as early
as practicable.
(c) Information and Education.--
(1) In general.--In carrying out subsection (b)(1),
the Secretary, in collaboration with the Secretary of
Education and the Secretary of Agriculture, shall,
subject to the availability of appropriations, provide
[culturally competent information] culturally and
linguistically responsive information regarding autism
spectrum disorder and other developmental disabilities,
risk factors, characteristics, identification,
diagnosis or rule out, and evidence-based interventions
to meet the needs of individuals with autism spectrum
disorder and other developmental disabilities across
their lifespan and the needs of their families
through--
(A) Federal programs, including--
(i) the Head Start program;
(ii) the Early Start program;
(iii) the Healthy Start program;
(iv) programs under the Child Care
and Development Block Grant Act of
1990;
(v) programs under title XIX of the
Social Security Act (particularly the
Medicaid Early and Periodic Screening,
Diagnosis and Treatment Program);
(vi) the program under title XXI of
the Social Security Act (the State
Children's Health Insurance Program);
(vii) the program under title V of
the Social Security Act (the Maternal
and Child Health Block Grant Program);
(viii) the program under parts B and
C of the Individuals with Disabilities
Education Act;
(ix) the special supplemental
nutrition program for women, infants,
and children established under section
17 of the Child Nutrition Act of 1966
(42 U.S.C. 1786); and
(x) the State grant program under the
Rehabilitation Act of 1973.
(B) State licensed child care facilities; and
(C) other community-based organizations or
points of entry for individuals with autism
spectrum disorder and other developmental
disabilities to receive services.
(2) Lead agency.--
(A) Designation.--As a condition on the
provision of assistance or the conduct of
activities under this section with respect to a
State, the Secretary may require the Governor
of the State--
(i) to designate a public agency as a
lead agency to coordinate the
activities provided for under paragraph
(1) in the State at the State level;
and
(ii) acting through such lead agency,
to make available to individuals and
their family members, guardians,
[advocates,] advocates, self-advocates,
or authorized representatives;
providers; and other appropriate
individuals in the State, comprehensive
[culturally competent information]
culturally and linguistically
responsive information about State and
local resources regarding autism
spectrum disorder and other
developmental disabilities, risk
factors, characteristics,
identification, diagnosis or rule out,
available services and supports (which
may include respite care for caregivers
of individuals with autism spectrum
disorder or other developmental
disabilities), and evidence-based
interventions.
(B) Requirements of agency.--In designating
the lead agency under subparagraph (A)(i), the
Governor shall--
(i) select an agency that has
demonstrated experience and expertise
in--
(I) autism spectrum disorder
and other developmental
disability issues; and
(II) developing,
implementing, conducting, and
administering programs and
delivering education,
information, and referral
services (including technology-
based cur